![New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? - ScienceDirect New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0021915020315872-gr1.jpg)
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? - ScienceDirect
How safe are these HDL, LDL, and triglycerides levels of 34, 110, 170 respectively for an overweight 29 year old male? - Quora
View of Excess cardiovascular risk in patients with type 2 diabetes: do we need to look beyond LDL cholesterol? | British Journal of Diabetes
![Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet](https://www.thelancet.com/cms/attachment/0c37580c-c143-4f36-88f9-6b0d46ba0da9/gr1_lrg.jpg)
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet
![Updated (2015) risk charts for estimation of absolute 10-year risk (%)... | Download Scientific Diagram Updated (2015) risk charts for estimation of absolute 10-year risk (%)... | Download Scientific Diagram](https://www.researchgate.net/publication/307969757/figure/fig3/AS:405484331913218@1473686406825/Updated-2015-risk-charts-for-estimation-of-absolute-10-year-risk-of-fatal-CVD-in.png)
Updated (2015) risk charts for estimation of absolute 10-year risk (%)... | Download Scientific Diagram
![JCM | Free Full-Text | Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers JCM | Free Full-Text | Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers](https://pub.mdpi-res.com/jcm/jcm-09-03748/article_deploy/html/images/jcm-09-03748-ag.png?1606353158)